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The minimally invasive approach is becoming the standard-of-care for surgery of the
mitral valve. As any less invasive strategy, it entails an increased surgical complexity.
Standard-of-caremitral repair using the totally videoscopic approach is indeed reprodu-
cible; however, few speciﬁc data onpatientswith complexmitral valve diseaseare avail-
able in the published literature. The purpose of the present paper is to provide an
overview of the current state-of-the-art in minimally invasive cardiac surgery, and a
summary of recent evidence on the topic, with particular regard to the surgical techni-
ques and comparisons with conventional surgery. The experience of the GVM Care and









Since the ﬁrst video-assisted mitral valve repair through a
minithoracotomy carried out in 19961 and the ﬁrst minim-
ally invasive mitral valve replacement in the same year,
an increasing enthusiasm has accompanied the develop-
ment of minimally invasive mitral valve surgery.1,2 The de-
velopment ofminimally invasive approaches in the cardiac
surgical domain is indeedcharacterizedbyentirely speciﬁc
challenges, i.e. the need to achieve both optimal myocar-
dial protection and reliable extracorporeal perfusion.3
Standardization of the procedures has been the key to
success for conventional cardiac surgery.
Four-step classiﬁcation of minimally invasive
mitral valve surgery
Usinganeffectiveanalogywithmountaineering, thedevel-
opment of minimally invasive mitral valve surgery and the
progression from less to more challenging surgical strat-
egies has been compared with the ascent of Mt Everest.
From ‘base camp’ (lower technical complexity), the
surgeon has moved towards more complex settings and
surgical installations: the advance has been progressive in-
volving, along the way, the mastering of less complex
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strategies (‘comfort zones’) through experience and accli-
matization.
Step 1:Direct vision. This represents theearliestminimally
invasive approaches to the mitral valve. These early
approaches were essentially based on the modiﬁcation
of previous conventional incisions; the very ﬁrst clinical
results reported low surgical mortality and morbidity,
and extracorporeal circulation and aortic clamping
times comparable with those observed in conventional
surgery. This context made possible the development
of intra-aortic balloon occluders, which would be
employed in the more advanced levels.
Step 2: Video-assisted techniques. The development of
the port-access system has been a milestone in this
progression. This strategy enabled a further signiﬁcant
reduction in the size of skin incisions. A part of the pro-
cedure is performed under a direct vision, and another
part is performed under video-assistance. The set-up
of the system includes peripheral cannulation, percu-
taneous transthoracic clamp, and percutaneous retro-
grade cardioplegia catheter.
Step 3:Video-directed and robot-assisted techniques. This
step (as well as the fourth) is less extensively used in
the practice worldwide. Concerning level 3, a voice-
activated robot camera is employed to avoid possible
communication errors if the camera is manoeuvred by
an assistant. Falk et al.4 published a case series suggest-
ing the feasibility of this approach.
Step 4: Telemanipulation and robotic surgery. The vey
initial experiences in this ﬁeld occurred in 1998 using
thedaVinci Surgical System.5 In this setting, the surgeon
interfaces with the patient using a distant console and
controls micro-wrist instruments operating inside the
patient’s body, in small spaces. Only thoracic ports are
needed as an access to the patient’s chest, besides a
very small minithoracotomy, the sole scope of which is
to insert the prosthetic material (mitral prosthetic
annuli or prosthetic valves) inside the patient.
Minimally invasive mitral repair: decision-making
issues
Although the criteria for patient selection, the surgical
techniques, andthephilosophiesmaydiffer among surgical
groups around the world, the overall clinical results from
the published literature are very encouraging and allow
anoverviewof the current state-of-the-art inminimally in-
vasive mitral operations, after almost 20 years of experi-
ence with these procedures. Generally speaking, mitral
repair itself can be considered as a ‘minimally invasive’
procedure compared with mitral replacement with either
a bioprosthesis or a mechanical valve. A minithoracotomy
as a surgical approach to the mitral valve actually facili-
tates exposure of the mitral valve itself in experienced
hands compared with full median sternotomy, since the
surgeon’s line of vision and work is directly towards the
plane of the valve.6 In median sternotomy, exposure and
‘working direction’ are less anatomical. This effect is par-
ticularly evident for the anterior mitral leaﬂet, due to its
upward position. Advancement of the camera just inside
the left ventricular cavity allows greatest precision in the
placement of artiﬁcial chordae and in the performance of
complex procedures such as papillary muscle reposition-
ing.7 A better exposure translates into better surgical
results, optimal stability of the repair and, therefore,
optimal long-term clinical results. This is corroborated by
published evidence showing a lesser likelihood of residual
mitral regurgitation with the minimally invasive approach
than with median sternotomy, and a greater likelihood of
successful repair for anterior leaﬂet disease if, similarly,
the minimally invasive approach is employed.8 It should
therefore be considered that, at the end of the learning
curve, the minimally invasive approach facilitates the
exposure of the mitral valve (Figures 1–3).
When it comes to the adoption of a given speciﬁcminim-
ally invasivemitral valve surgery protocol, we believe that
in choosing one should aim at the optimal standardization
and reproducibility in compliance with local conditions.
Major problems associatedwith the development of amin-
imally invasive mitral valve surgery programme are the
technical complexity, the long learning curve, and the hos-
pital costs. Procedures should be planned to be as simple
and straightforward as possible. Robotic surgery (although
itmay offer advantages in terms of skin length incision) un-
doubtedly entails a growing level of complexity and signiﬁ-
cant costs due to the nature itself of the high technology
equipment and consumables.We draw attention to the im-
portance of performing cost-effective procedures in the
current period characterized by a progressive diminish-
ment of state and private funds for healthcare. In this
context, future reimbursement policies from both state
and private insurance institutionsmay privilege the proce-
dures that guarantee the best ratio of social costs to meas-
urable indexes of health and to patient reported outcomes
(PROs) measuring patient satisfaction. Parameters such as
the quality-adjusted life years are increasingly used in this
domain, and we believe that studies based on the assess-
ment of such parameters should become part of the long-
term armamentarium to evaluate the outcome of patients
who undergo mitral valve operations.
Minimally invasive mitral valve surgery is essentially
team-based work. Cardiac surgeons need to collaborate
with anaesthesiologists, dedicated cardiologists, and in-
tensivists within a heart team. The correct establishment
of surgical indications and the adequate planning of the
procedures rely on the skills of echocardiographers, who
represent a key ﬁgure of the minimally invasive surgery
programme of an institution. Transoesophageal echocardi-
ography not only allows to precisely determine the mech-
anism underlying the valve dysfunction, but also assists in
the percutaneous cannulation and in the de-airing man-
oeuvres, and conﬁrms the effectiveness of repair after
weaning from cardiopulmonary bypass.
In our opinion, there are a few contraindications to min-
imally invasive mitral valve surgery performed through a
right minithoracotomy. They include: previous surgery
within the right pleural space (which may determine
severe intrapleural adhesions), non-elective priority (sur-
geons on duty may not have sufﬁcient expertise or may
not have access during night hours to the complete
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minimally invasive material required), incapacity to toler-
ate right lung exclusion and, as a relative contraindication,
severe obesity or chest wall deformities. Such cases should
be evaluated individually.
Why minimally invasive mitral valve surgery?
Any reﬂection on the advantages, evolution, drawbacks,
and limits of minimally invasive mitral valve surgery must
be based on a straightforward analysis of the literature in
peer-reviewed journals, as the expression of the collective
experience of the surgical community. The literature
should be systematically analysed in order to clarify one
by one all issues associated with this complex clinical
reality. Concerning operative mortality, the conclusion
from examining the major case series is that we cannot
detect any signiﬁcant difference between minimally inva-
sive and conventional procedures. A matched analysis
found no difference in in-hospital mortality betweenmini-
thoracotomy and sternotomy operated patients (3.7 vs.
3.4%),9 despite the considerably longer cardiopulmonary
bypass times in the minimally invasive surgery group. This
result is conﬁrmed in several major series.10 Interesting
investigationshaveexamined throughtranscranialDoppler
the presence of microemboli within the cerebral circula-
tion after conventional external cross-clamping through a
sternotomy incision vs. in patients who were treated with
an endoaortic balloon occluder: no signiﬁcant intergroup
difference could be detected.11 There is debate over the
question whether minimally invasive mitral valve surgery
could actually decrease the blood loss and transfusion
requirements compared with conventional surgery. Full
Figure 2 GVM 1-month mortality in mitral valve repair.
Figure 1 GVM experience in mitral valve repair standard vs. minimally invasive approach.
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median sternotomy entails a larger tissue disruption,
whereas a minimally invasive access minimizes the expos-
ureof the interioraspectof thechestwall and thepotential
sources of bleeding. In fact, several comparative studies
have indicated reduced early blood loss afterminimally in-
vasive strategy, despite longer cardiopulmonary bypass
times. A lower rate of surgical site infections has also
been documented, with an inherent reduction of major
complications,which carry increasedassociatedmortality,
such as sternal infection and mediastinitis. Most studies
also underline a signiﬁcant reduction in postoperative
pain with a minimally invasive approach, as well as lesser
requirement of analgesic medications and a facilitated re-
covery of pulmonary function12 expected through the pre-
servingof thepatient’s ventilatormechanicsmadepossible
due to the sternal integrity. Interestingly, patients who
received a reoperation through a minimally invasive
approach after previous primary surgery through full ster-
notomy tend to report that their recovery was easier and
faster after minimally invasive surgery.
The elderly represent a particular patient subgroup
often characterized by multiple comorbidities and a vari-
able degree of frailty. It has been asked whether the
minimally invasive approach may diminish the operative
risk among elderly patients affected by severe mitral
valve disease. Findings have been reported in the elderly
showing a lower mortality rate, and shorter hospital
and intensive care unit stays with the minimally invasive
approach when compared with median sternotomy.13
However, the seemingly obvious notion that faster recov-
ery translates into cost-savings and shorter hospitalization
is not backed up by a consistent body of evidence in the lit-
erature. Differences in local protocols of postoperative
hospitalization length may be responsible for a bias in this
respect.
The minimally invasive strategy may prove particularly
useful in the context of cardiac reoperations: theminithor-
acotomy access to the mitral valve avoids the sternal
re-entry and intrapericardial dissection, with the asso-
ciated risks of injury and bleeding. Patients with patent
coronary grafts are particularly vulnerable in this respect.
Our experience
Between January 2009 and September 2014, 2267 patients
with mitral valve regurgitation have undergone surgical
procedures in our hospitals (GVM Care and Research).
Mitral valve repair for degenerativediseaseswas performed
in 1758 patients. Among them, 665 patients underwent
valve repair using a minimally invasive approach. The rate
of using this approach has increased steadily since 2009,
to now represent 50% of cases operated in 2013–14.
Currently, more than 12 surgeons are involved in mitral
valve repair within eight different centres. The in-hospital
mortality rate for the overall period 2009–14 was 1.4%.
The mean in-hospital stay was 10.5 days for minimally
invasive surgery vs. 11.1 days for standard full sternotomy.
The incidence rate of revision for postoperative bleeding
was 0.14% for minimally invasive access vs. 0.21% for stand-
ard full sternotomy. The rate of successful mitral valve
repair was .77% in all centres, while it was higher
than 95% in the three centres with .100 cases/year.
Within the hospitals with highest valve repair volume
(.50 cases/year), we observed a mortality rate of ,1%.
Overall, our data suggest that the minimally invasive
approach can be introduced into routine surgical practice
without compromising the repair results, while improving
the postoperative outcomes.
Conclusions
In conclusion, minimally invasive strategies corresponding
to level 2 (see four-step classiﬁcation above) represent in
our experience a very good compromise between reprodu-
cibility of the procedure and achievement of major advan-
tages associated with the minimal incisions. Moreover,
experienced surgeons and high-volume hospitals also con-
tribute to further ameliorate the outcomes and minimize
the mortality rate.
Conﬂict of interest: none declared.
Figure 3 Number of postoperative complications.
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